# Nuclear Imaging for Subtype Diagnosis of Primary Aldosteronism

> **NCT05472493** · PHASE2 · RECRUITING · sponsor: **University of Calgary** · enrollment: 30 (estimated)

## Conditions studied

- Primary Aldosteronism

## Interventions

- **BIOLOGICAL:** [18-F]CETO

## Key facts

- **NCT ID:** NCT05472493
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05472493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05472493, "Nuclear Imaging for Subtype Diagnosis of Primary Aldosteronism". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05472493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*